BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND RPL22, EAP, 6146
74 results:

  • 1. L22 ribosomal protein is involved in dynamin-related protein 1-mediated gastric carcinoma progression.
    Cheng J; Sha Z; Zhang R; Ge J; Chen P; Kuang X; Chang J; Ren K; Luo X; Chen S; Gou X
    Bioengineered; 2022 Mar; 13(3):6650-6664. PubMed ID: 35230214
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Silencing Ribosomal Protein L22 Promotes Proliferation and Migration, and Inhibits Apoptosis of gastric cancer Cells by Regulating the Murine Double Minute 2-Protein 53 (MDM2-p53) Signaling Pathway.
    Sun Z; Qiu Z; Wang Z; Chi H; Shan P
    Med Sci Monit; 2021 May; 27():e928375. PubMed ID: 34050122
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clonal Structures of Regionally Synchronous gastric Adenomas and Carcinomas.
    Jung SH; Kim SY; An CH; Lee SH; Jung ES; Park HC; Kim MS; Chung YJ; Lee SH
    Clin Cancer Res; 2018 Oct; 24(19):4715-4725. PubMed ID: 29945994
    [No Abstract]    [Full Text] [Related]  

  • 4. Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean cancer Study Group (KCSG).
    Jung M; Ryu MH; Oh DY; Kang M; Zang DY; Hwang IG; Lee KW; Kim KH; Shim BY; Song EK; Sym SJ; Han HS; Park YL; Kim JS; Lee HW; Lee MH; Koo DH; Song HS; Lee N; Yang SH; Choi DR; Hong YS; Lee KE; Maeng CH; Baek JH; Kim S; Kim YH; Rha SY; Cho JY; Kang YK
    Gastric Cancer; 2018 Sep; 21(5):819-830. PubMed ID: 29427038
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Extended antimicrobial prophylaxis after gastric cancer surgery: a systematic review and meta-analysis.
    Zhang CD; Zeng YJ; Li Z; Chen J; Li HW; Zhang JK; Dai DQ
    World J Gastroenterol; 2013 Apr; 19(13):2104-9. PubMed ID: 23599632
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial.
    Kulig J; Kolodziejczyk P; Sierzega M; Bobrzynski L; Jedrys J; Popiela T; Dadan J; Drews M; Jeziorski A; Krawczyk M; Starzynska T; Wallner G
    Oncology; 2010; 78(1):54-61. PubMed ID: 20215786
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Local recurrence following adjuvant chemotherapy without radiotherapy in completely resected stomach and gastroesophageal junction adenocarcinoma.
    Bar-Sela G; Tsalic M; Steiner M; Wollner M; Haim N
    Anticancer Res; 2009 May; 29(5):1853-6. PubMed ID: 19443416
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Bimonthly 24 h infusion of high-dose 5-fluorouracil vs eap regimen in patients with advanced gastric cancer. A randomized phase II study.
    Popov IP; Jelić SB; Krivokapić ZV; Jezdić SD; Pesko PM; Micev MT; Babić DR
    Med Oncol; 2008; 25(1):73-80. PubMed ID: 17972024
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Immunoregulation and short-term therapeutic effects of super-selective intra-arterial chemotherapy combined with traditional Chinese drugs on gastric cancer patients].
    Zhu JS; Song MQ; Wang L; Sun Q; Zhu L; Fang C
    Zhong Xi Yi Jie He Xue Bao; 2006 Sep; 4(5):478-81. PubMed ID: 16965740
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Disciplinarian of lymph node metastasis and effect of paraaortic lymph nodes dissection on clinical outcomes in advanced gastric carcinoma].
    Zhan WH; Han FH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):17-22. PubMed ID: 16437364
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mobilization of peripheral blood stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in advanced gastric cancer.
    Ueda Y; Sonoda Y; Fujiki H; Harada S; Kimura T; Itoh T; Imura K; Naito K; Nomura K; Taniwaki M; Yamagishi H
    Oncol Rep; 2004 Aug; 12(2):323-32. PubMed ID: 15254697
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A multimodal treatment approach including high-dose chemotherapy in very advanced gastric cancer: evidence for control of metastatic disease.
    Reichle A; Bolder U; Bataille F; Messmann H; Wagner H; Zaiss M; Wild P; Hofstädter F; Andreesen R; Jauch KW
    Bone Marrow Transplant; 2003 Oct; 32(7):665-71. PubMed ID: 13130313
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate.
    Menges M; Schmidt C; Lindemann W; Ridwelski K; Pueschel W; Jüngling B; Feifel G; Schilling M; Stallmach A; Zeitz M
    J Cancer Res Clin Oncol; 2003 Jul; 129(7):423-9. PubMed ID: 12836016
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Etoposide, doxorubicin and cisplatin alternating with 5-fluorouracil, doxorubicin and high-dose methotrexate in patients with advanced adenocarcinoma of the stomach or the gastroesophageal junction.
    Bar Sela G; Tsalic M; Gaitini D; Steiner M; Haim N
    J Chemother; 2002 Dec; 14(6):623-6. PubMed ID: 12583555
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [A gastric cancer patient with marked para-aortic lymph node metastasis surviving more than 10 years after aggressive operation and repeated eap chemotherapy].
    Uchinami M; Horiuchi T; Aotake T; Matsumura M; Yokomachi J; Tanaka K; Tabo T; Tanigawa N
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):449-53. PubMed ID: 11915738
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group.
    Bajetta E; Buzzoni R; Mariani L; Beretta E; Bozzetti F; Bordogna G; Aitini E; Fava S; Schieppati G; Pinotti G; Visini M; Ianniello G; Di BM
    Ann Oncol; 2002 Feb; 13(2):299-307. PubMed ID: 11886009
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) in locally advanced or metastatic gastric cancer: a single institution experience.
    Aitini E; Rabbi C; Mambrini A; Cavazzini G; Pari F; Zamagni D; Cantore M; Pagani M; Sorio M; Lusenti A; Adami F; Smerieri F
    Tumori; 2001; 87(1):20-4. PubMed ID: 11669552
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Advanced gastric cancer with multiple lymph node metastasis successfully treated with etoposide, adriamycin and cisplatin.
    Shigemitsu K; Naomoto Y; Matsuno T; Gochi A; Isozaki H; Tanaka N
    J Gastroenterol Hepatol; 2001 May; 16(5):581-5. PubMed ID: 11350560
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Surgical and combined treatment of gastric cancer--own experience.
    Berner J; Tenderenda M; Pasz S; Berner A; Piekarski J
    Przegl Lek; 2000; 57 Suppl 5():14-5. PubMed ID: 11202279
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long-term results of a phase-II-pilot trial on preoperative high-dose chemotherapy with stem cell rescue in patients with cancer of the upper gastrointestinal tract.
    Berdel WE; Heldmann T; Thiel E
    Oncol Rep; 2001; 8(2):341-2. PubMed ID: 11182052
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.